A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Latest Information Update: 23 Jul 2025
At a glance
- Drugs Belinostat (Primary) ; Cisplatin (Primary) ; Etoposide (Primary)
- Indications Bone metastases; Neuroendocrine carcinoma; Prostate cancer
- Focus Therapeutic Use
Most Recent Events
- 17 Jul 2025 Planned initiation date (estimated date for recruitment of the first subject) changed to 22 Jul 2025.
- 27 Jun 2025 Planned initiation date changed from 26 Jun 2025 to 2 Jul 2025.
- 22 Jun 2025 Planned initiation date changed to 26 Jun 2025.